LUNDBECK PHARMA A/S: Financial statements 2023
CVR: 56750215
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
LUNDBECK PHARMA A/S (CVR 56750215) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 15,968,000 and a net result of DKK 991,000 compared with DKK 982,000 the year before. That is a decrease of 5.8% compared with the year before. The profit margin was 6.2%. Equity in the 2023 report amounted to DKK 2,535,000. The solvency ratio was 15.2%.
- Revenue
- DKK 15,968,000
- Gross Profit
- DKK 2,583,000
- Profit/Loss
- DKK 991,000
- Equity
- DKK 2,535,000
- Total Assets
- DKK 16,719,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 16M | 2.6M | 991K | 2.5M | - |
| 2022 | 17M | 2.3M | 982K | 2.3M | - |
| 2021 | 16.5M | 3.2M | 1.2M | 2.4M | 20 |
| 2020 | 19.2M | 1.3M | -5.1M | -1.6M | 20 |
| 2019 | 17.3M | 1.3M | 497K | 3.7M | 18 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
LUNDBECK PHARMA A/S has published its annual report for 2022. Revenue came to DKK 16,955,000, and the net result was DKK 982,000.
About LUNDBECK PHARMA A/S
LUNDBECK PHARMA A/S is a Danish company of the type Aktieselskab based in Valby, founded in 1958. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HANS LUNDBECK A/S. The management consists of Søren Klein-Kristensen. The board consists of Michala Fischer-Hansen (chair), Søren Klein-Kristensen and Thomas Bo Bjørn Klee. The company is owned by H. LUNDBECK A/S. The company has 17 employees (2026). In 2025, the company reported revenue of DKK 18,887,000 and a net result of DKK 2,291,000 compared with DKK 1,820,000 the year before. Equity in the 2025 report amounted to DKK 3,378,000.